SEEBRI BREEZHALER

Identification of Seebri Breezhaler

No description

Google image searchProduct monograph

Active ingredient

glycopyrronium (glycopyrronium bromide), 50 MCG

DIN: 02394936

Dosage form(s): CAPSULE

Route(s) of administration: INHALATION

Description: CAPSULES TO BE USED ONLY WITH SEEBRI BREEZHALER INHALATION DEVICE - ORAL INHALATION

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 14-JAN-2013

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03B — OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS (ATC, ATC/DDD)
• R03BB — Anticholinergics (ATC, ATC/DDD)
• R03BB06 — GLYCOPYRRONIUM BROMIDE (ATC/DDD)

Reference brand drug: Seebri

External Links for Seebri Breezhaler

Search on Google

• Seebri Breezhaler side effects
• Seebri Breezhaler dosage
• glycopyrronium side effects
• glycopyrronium dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find seebri breezhaler photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.